Page last updated: 2024-08-23

norgestimate and Osteoporosis, Postmenopausal

norgestimate has been researched along with Osteoporosis, Postmenopausal in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arrenbrecht, S; Caubel, P; Felsenberg, D; Garnero, P1
Sobel, NB1

Reviews

1 review(s) available for norgestimate and Osteoporosis, Postmenopausal

ArticleYear
Progestins in preventive hormone therapy. Including pharmacology of the new progestins, desogestrel, norgestimate, and gestodene: are there advantages?
    Obstetrics and gynecology clinics of North America, 1994, Volume: 21, Issue:2

    Topics: Breast Neoplasms; Cardiovascular Diseases; Desogestrel; Endometrium; Estrogen Replacement Therapy; Female; Humans; Norgestrel; Norpregnenes; Osteoporosis, Postmenopausal; Progesterone Congeners; Risk Factors; Structure-Activity Relationship

1994

Trials

1 trial(s) available for norgestimate and Osteoporosis, Postmenopausal

ArticleYear
The effect of continuous oestradiol with intermittent norgestimate on bone mineral density and bone turnover in post-menopausal women.
    Maturitas, 2004, Jul-15, Volume: 48, Issue:3

    Topics: Aged; Body Mass Index; Bone and Bones; Bone Density; Contraceptives, Oral, Synthetic; Drug Administration Schedule; Estradiol; Female; Humans; Middle Aged; Norgestrel; Osteoporosis, Postmenopausal; Patient Dropouts; Patient Selection; Treatment Outcome

2004